{"id":11371,"date":"2021-10-27T16:38:29","date_gmt":"2021-10-27T14:38:29","guid":{"rendered":"https:\/\/www.maiwald.eu\/?post_type=publikationen&#038;p=11371"},"modified":"2022-03-31T17:27:28","modified_gmt":"2022-03-31T15:27:28","slug":"germany-ema-and-eu-commission-offer-flexibility-instead-of-intervention","status":"publish","type":"publikationen","link":"https:\/\/www.maiwald.eu\/de\/publikationen\/germany-ema-and-eu-commission-offer-flexibility-instead-of-intervention\/","title":{"rendered":"Alignment of Pharmaceutical Strategy for Europe with the Action Plan on IP, 2021"},"content":{"rendered":"\n<p>von <a href=\"https:\/\/www.maiwald.eu\/team\/gisela-grabow\/\">Dr. Gisela Grabow<\/a><\/p>\n\n\n\n<p>in Managing Intellectual Property<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-11371","publikationen","type-publikationen","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.maiwald.eu\/de\/wp-json\/wp\/v2\/publikationen\/11371","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.maiwald.eu\/de\/wp-json\/wp\/v2\/publikationen"}],"about":[{"href":"https:\/\/www.maiwald.eu\/de\/wp-json\/wp\/v2\/types\/publikationen"}],"version-history":[{"count":7,"href":"https:\/\/www.maiwald.eu\/de\/wp-json\/wp\/v2\/publikationen\/11371\/revisions"}],"predecessor-version":[{"id":16969,"href":"https:\/\/www.maiwald.eu\/de\/wp-json\/wp\/v2\/publikationen\/11371\/revisions\/16969"}],"wp:attachment":[{"href":"https:\/\/www.maiwald.eu\/de\/wp-json\/wp\/v2\/media?parent=11371"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}